Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000458863 | SCV000559362 | likely benign | Rhabdoid tumor predisposition syndrome 2 | 2024-04-08 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV001020187 | SCV001181633 | likely benign | Hereditary cancer-predisposing syndrome | 2017-09-25 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Fulgent Genetics, |
RCV002489119 | SCV002804255 | likely benign | Rhabdoid tumor predisposition syndrome 2; Intellectual disability, autosomal dominant 16 | 2022-05-24 | criteria provided, single submitter | clinical testing |